BridgeMD

Sign in

Autoimmune Pulmonary Alveolar Proteinosis clinical trials

Explore recruiting autoimmune pulmonary alveolar proteinosis clinical trials.

Recruiting autoimmune pulmonary alveolar proteinosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autoimmune Pulmonary Alveolar Proteinosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP)

Romania, Italy, Spain, Germany, Poland, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Inhaled Molgramostim in Pediatric Subjects with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Autoimmune Pulmonary Alveolar Proteinosis trials by city

Autoimmune Pulmonary Alveolar Proteinosis in Toronto Autoimmune Pulmonary Alveolar Proteinosis in Vancouver Autoimmune Pulmonary Alveolar Proteinosis in Montreal Autoimmune Pulmonary Alveolar Proteinosis in Calgary Autoimmune Pulmonary Alveolar Proteinosis in Edmonton Autoimmune Pulmonary Alveolar Proteinosis in Ottawa Autoimmune Pulmonary Alveolar Proteinosis in Winnipeg Autoimmune Pulmonary Alveolar Proteinosis in Quebec City Autoimmune Pulmonary Alveolar Proteinosis in Hamilton Autoimmune Pulmonary Alveolar Proteinosis in Kitchener Autoimmune Pulmonary Alveolar Proteinosis in London Autoimmune Pulmonary Alveolar Proteinosis in Halifax Autoimmune Pulmonary Alveolar Proteinosis in New York Autoimmune Pulmonary Alveolar Proteinosis in Los Angeles Autoimmune Pulmonary Alveolar Proteinosis in Chicago Autoimmune Pulmonary Alveolar Proteinosis in Houston